KALA AZAR
- Kala-azar, also known as visceral leishmaniasis or black fever, is a potentially deadly parasitic disease caused by protozoa of the Leishmania genus.
- The main species responsible for the disease are Leishmania donovani and Leishmania infantum. The disease is transmitted to humans through the bites of infected female sandflies, primarily of the genus Phlebotomus in the Old World and Lutzomyia in the New World.
- Kala-azar affects the internal organs, such as the liver, spleen, and bone marrow, leading to symptoms such as prolonged fever, weight loss, enlargement of the spleen and liver, and anemia.
- The name "kala-azar" translates to "black fever" in Hindi and refers to the darkening of the skin that can occur in some cases.
- The disease is endemic in certain regions of Africa, Asia, and South America, where conditions are favorable for the survival of the sandfly vector.
- Kala-azar can be a serious public health concern, especially in impoverished areas with limited access to healthcare. Treatment typically involves antimonial drugs, but drug resistance has been a concern in some regions.
- Efforts to control and eliminate kala-azar involve vector control measures, early diagnosis, and treatment of cases, as well as research into new treatment options and vaccines
- In 2020, over 90% of newly reported cases to the World Health Organization (WHO) were concentrated in ten countries: Brazil, China, Ethiopia, Eritrea, India, Kenya, Somalia, South Sudan, Sudan, and Yemen.
- Notably, Bangladesh achieved the distinction of being the first country globally to be officially recognized by the WHO for successfully eliminating kala-azar as a public health concern in October 2023. India is now tasked with maintaining its progress in the coming three years to attain WHO certification.
- As of October this year, India documented 530 cases and four fatalities attributed to the infection, representing a decline from 891 cases and three deaths in 2022. The figures for 2021 indicated 1,357 cases and eight deaths.
- Additionally, there were 286 reported instances of post-kala azar dermal leishmaniasis (PKDL) by October 2023. The complete cure of this skin condition is imperative, as it can serve as a reservoir for the parasite
-
Prolonged Fever: Persistent and irregular bouts of fever that may last for weeks or months.
-
Weight Loss: Unexplained and significant weight loss.
-
Enlarged Spleen (Splenohepatomegaly): The spleen often becomes enlarged, leading to abdominal discomfort.
-
Enlarged Liver: Hepatomegaly, or enlargement of the liver, can also occur.
-
Anemia: Reduced red blood cell count, leading to fatigue, weakness, and pallor.
-
Jaundice: Yellowing of the skin and eyes due to liver involvement.
-
Swollen Lymph Nodes: Lymph nodes may become enlarged.
-
Discoloration of the Skin: In some cases, the skin may darken, leading to the term "kala-azar" or black fever.
- Targeting the sandfly vectors that transmit the Leishmania parasites is a crucial aspect of the elimination program. This may involve the use of insecticide-treated bed nets, indoor residual spraying, and environmental management to reduce sandfly breeding sites
- Timely diagnosis and treatment of kala-azar cases are essential to prevent the spread of the disease. Access to accurate diagnostic tools and effective antiparasitic drugs is a priority
- Implementing surveillance systems to monitor the prevalence of kala-azar, track new cases, and assess the effectiveness of control measures is integral to the elimination program.
- Strengthening the capacity of healthcare systems, including training healthcare workers, improving laboratory facilities, and enhancing overall infrastructure, is vital for successful implementation.
- Involving communities in awareness campaigns, education, and active participation in control measures can enhance the program's effectiveness. Community engagement fosters cooperation, early reporting of cases, and adherence to preventive measures.
- Ongoing research into new treatment options, diagnostic tools, and potential vaccines is important for advancing the understanding of the disease and improving control strategies.
- Kala-azar often transcends national borders, so collaboration between neighboring countries is crucial to effectively address the movement of the disease and implement coordinated control measures
National Vector Borne Disease Control Program (NVBDCP) is a comprehensive public health initiative in India that focuses on the prevention and control of vector-borne diseases. The program is implemented by the Ministry of Health and Family Welfare, Government of India. While the specific details of programs may evolve, as of my last update, the NVBDCP primarily addresses diseases such as malaria, dengue, chikungunya, lymphatic filariasis, and kala-azar (visceral leishmaniasis).
Key components and activities of the National Vector Borne Disease Control Program include:
- The program involves the surveillance and monitoring of vector-borne diseases to track their prevalence, identify high-risk areas, and assess the effectiveness of control measures.
- Implementation of strategies to control the vectors responsible for transmitting diseases. This includes measures such as insecticide-treated bed nets, indoor residual spraying, larval control, and environmental management.
- Conducting awareness campaigns and health education programs to inform communities about preventive measures, early symptoms, and the importance of seeking medical care.
- Supporting research initiatives to improve the understanding of vector-borne diseases, develop innovative control methods, and enhance the overall effectiveness of disease prevention and control strategies.
India faces several vector-borne diseases, where the transmission of these diseases occurs through the bites of infected vectors such as mosquitoes, ticks, and sandflies. Some of the significant vector-borne diseases in India include:
-
Malaria: Transmitted by Anopheles mosquitoes, malaria is a parasitic infection caused by Plasmodium parasites. It remains a major public health concern in various parts of India.
-
Dengue Fever: A viral infection transmitted by Aedes mosquitoes, particularly Aedes aegypti. Dengue fever has periodic outbreaks in different regions of India.
-
Chikungunya: Caused by the chikungunya virus and transmitted by Aedes mosquitoes, this disease leads to fever and severe joint pain. Outbreaks occur intermittently in India.
-
Lymphatic Filariasis: Commonly known as elephantiasis, this disease is caused by filarial worms and transmitted by Culex mosquitoes. The National Filaria Control Program aims to eliminate this disease in India.
-
Kala-azar (Visceral Leishmaniasis): Caused by the Leishmania parasite and transmitted by sandflies, kala-azar affects internal organs. The National Kala Azar Elimination Program works towards controlling and eliminating this disease.
-
Japanese Encephalitis (JE): A viral infection transmitted by Culex mosquitoes, JE can lead to inflammation of the brain. Vaccination campaigns are conducted in endemic regions to prevent outbreaks.
-
Zika Virus: Although not as widespread, the Zika virus can be transmitted by Aedes mosquitoes. Cases of Zika have been reported in some parts of India.
-
Rickettsial Infections: Diseases like scrub typhus and spotted fever are caused by bacteria transmitted through the bites of infected mites and ticks
